AWM
BNTX icon

Atticus Wealth Management’s BioNTech BNTX Stock Holding History

Atticus Wealth Management’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-2
Closed -$213 – 254
2025
Q2 		$213 Hold
2
– – ﹤0.01% 667
2025
Q1 		$183 Hold
2
– – ﹤0.01% 497
2024
Q4 		$228 Hold
2
– – ﹤0.01% 512
2024
Q3 		$238 Hold
2
– – ﹤0.01% 508
2024
Q2 		$161 Hold
2
– – ﹤0.01% 521
2024
Q1 		$185 Hold
2
– – ﹤0.01% 533
2023
Q4 		$212 Hold
2
– – ﹤0.01% 542
2023
Q3 		$218 Sell
2
-17
-89% -$1.88K ﹤0.01% 568
2023
Q2 		$2.05K Hold
19
– – ﹤0.01% 494
2023
Q1 		$2.37K Hold
19
– – ﹤0.01% 466
2022
Q4 		$2.85K Sell
19
-1
-5% -$154 ﹤0.01% 445
2022
Q3 		$3K Hold
20
– – ﹤0.01% 463
2022
Q2 		$3K Hold
20
– – ﹤0.01% 495
2022
Q1 		$3K Hold
20
– – ﹤0.01% 489
2021
Q4 		$5K Sell
20
-9
-31% -$2.46K ﹤0.01% 389
2021
Q3 		$8K Buy
+29
New +$9.22K ﹤0.01% 351

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Atticus Wealth Management's BNTX Position: Q3 2025 in Review

Atticus Wealth Management sold out of BioNTech (BNTX) in Q3 2025, closing a stake of 2 shares — an estimated $213 sold.

Atticus Wealth Management first reported a position in BNTX in Q3 2021 and held it in 16 quarters. The position peaked at $8K in Q3 2021. 254 funds tracked by Wall St. Rank hold BNTX as of Q3 2025.

  • Atticus Wealth Management reported no remaining BioNTech position as of Q3 2025 after selling out during the quarter.
  • Atticus Wealth Management sold 2 BioNTech shares in Q3 2025, an estimated $213.
  • Atticus Wealth Management first reported a position in BioNTech in Q3 2021 and held it in 16 quarters.
  • Atticus Wealth Management's BioNTech position peaked at $8K in Q3 2021.
  • 254 funds tracked by Wall St. Rank held BioNTech as of Q3 2025.

Based on Atticus Wealth Management's 13F filing for Q3 2025, filed 7 Nov 2025.